Connect with us


Indiva (OTCMKTS:NDVAF) Pronounces The Addition Of Dycar To Its B2B Platform



Indiva (OTCMKTS:NDVAF) has today announced the addition of Dycar Pharmaceuticals Ltd to its B2B platform. The two business giants move into a strategic partnership, hoping to boost business revenues significantly.

A close outlook at the agreement

The Chief Executive Officer of Indiva Niel Marotta describes Dycar as a top-quality partner that they have been privileged to work with. He outlines that they share common interests, and that will help them work together smoothly. Both of these companies are inclined to the delivery of leading and top quality products to the market.

Marotta says that they are ready to start the business collaboration by cooperating fully with the team from Dycar. The common goal is to formulate new products that conform to customer and consumer expectations.

Indiva is also quite pleased to disclose details about its new financing. It is a convertible debenture form of business financing that is worth $4 million.

State of affairs

The new working relationship between these two is a progressive white-label manufacturing deal with wide-ranging benefits. Indiva discloses that the terms of the deal are quite clear and that Dycar is ready to play its part. It is required to serve the partner with $3.1 million in the form of non-dilutive financing. This will be the initial amount given out.

On the other hand, Indiva is expected to fulfill its end of the bargain. This will be the manufacture and distribution of some particular cannabis products with the Dycar brand on them. The business giant has a licensed facility in Ontario, and this is where the manufacturing activities will be taking place.

The deal also provides that Dycar will repay Indiva for its services. This will be done by deducting the value of Indiva services according to the signed deal. There will also be an opportunity for the renewal of the letter agreement. However, that will be at a minimum of about two additional terms. This may require an additional payment of about $4.5 million again in the form of non-dilutive financing.

Indiva is chatting the way forward into the future. The Q1 2020 is when it commences the production of the wide-ranging Dycar branded products.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.